Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Canner

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. External quality control programsP L Canner, W F Krol, S A Forman
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: I. Practical considerationsP L Canner, Y B Huang, C L Meinert
JAMA|June 29, 2000
Early risks of hormone therapy in patients with coronary heart diseaseN K Wenger, G L Knatterud, P L Canner
International Journal of Clinical Practice|March 26, 2013
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucoseV Sazonov, D Maccubbin, C McCrary Sisk, et al.
Circulation|August 1, 1982
The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug projectR C Schlant, S Forman, J Stamler, et al.
Investigative Ophthalmology & Visual Science|July 1, 1985
Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10L I Rand, G J Prud'homme, F Ederer, et al.
Controlled Clinical Trials|March 1, 1987
External monitoring of a data coordinating center: experience of the National Cooperative Gallstone StudyP L Canner, L C Gatewood, C White, et al.
Controlled Clinical Trials|August 1, 1997
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.
American Journal of Epidemiology|August 15, 1991
The Hypertension Prevention Trial: assessment of the quality of blood pressure measurementsP L Canner, N O Borhani, A Oberman, et al.
Journal of the American College of Cardiology|December 1, 1986
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacinP L Canner, K G Berge, N K Wenger, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. External quality control programsP L Canner, W F Krol, S A Forman
Controlled Clinical Trials|September 1, 1981
On the detection of outlier clinics in medical and surgical trials: I. Practical considerationsP L Canner, Y B Huang, C L Meinert
JAMA|June 29, 2000
Early risks of hormone therapy in patients with coronary heart diseaseN K Wenger, G L Knatterud, P L Canner
International Journal of Clinical Practice|March 26, 2013
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucoseV Sazonov, D Maccubbin, C McCrary Sisk, et al.
Circulation|August 1, 1982
The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug projectR C Schlant, S Forman, J Stamler, et al.
Investigative Ophthalmology & Visual Science|July 1, 1985
Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10L I Rand, G J Prud'homme, F Ederer, et al.
Controlled Clinical Trials|March 1, 1987
External monitoring of a data coordinating center: experience of the National Cooperative Gallstone StudyP L Canner, L C Gatewood, C White, et al.
Controlled Clinical Trials|August 1, 1997
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.
American Journal of Epidemiology|August 15, 1991
The Hypertension Prevention Trial: assessment of the quality of blood pressure measurementsP L Canner, N O Borhani, A Oberman, et al.
Journal of the American College of Cardiology|December 1, 1986
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacinP L Canner, K G Berge, N K Wenger, et al.
Pageof 3